Orphan Drug Designation
Search documents
Cadrenal Therapeutics(CVKD) - Prospectus
2023-07-24 13:15
As filed with the Securities and Exchange Commission on July 24, 2023 Registration Statement No 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cadrenal Therapeutics, Inc. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 88-0860746 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 822 A1 ...
Qualigen Therapeutics(QLGN) - Prospectus
2023-06-13 21:15
As filed with the Securities and Exchange Commission on June 13, 2023. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Qualigen Therapeutics, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 2834 26-3474527 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) Qualigen Thera ...
Cadrenal Therapeutics(CVKD) - Prospectus(update)
2023-01-17 12:31
800 Third Avenue New York, New York 10022 Tel: (212) 730-7700 As filed with the Securities and Exchange Commission on January 17, 2023. Registration No. 333-267562 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 6 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cadrenal Therapeutics, Inc. (Exact name of registrant as specified in its charter) | Delaware 2834 | 88-0860746 | | --- | --- | | (State or other jurisdiction of (Primary Standard Industrial | ...